Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: ResMed Inc., 2 years.
ResMed Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ResMed Inc. November 19, 202598.3%
-
ResMed Inc. November 20, 202499.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Ulta Beauty Inc. | Grant or award | +4,219 | — | — |
| Dec 9, 2025 | Ulta Beauty Inc. | Grant or award | +1,825 | — | — |
| Dec 9, 2025 | Ulta Beauty Inc. | Grant or award | +3,649 | — | — |
| Nov 26, 2025 | Becton Dickinson and Company | Grant or award | +6,006 | — | — |
| Nov 26, 2025 | Becton Dickinson and Company | Shares withheld for tax | −4,245 | — | — |
| Nov 20, 2025 | ResMed Inc. | Grant or award | +1,073 | — | — |
| Sep 1, 2025 | Becton Dickinson and Company | Shares withheld for tax | −278 | — | — |
| Nov 26, 2024 | Becton Dickinson and Company | Grant or award | +4,884 | — | — |
| Nov 26, 2024 | Becton Dickinson and Company | Grant or award | +9,015 | — | — |
| Nov 26, 2024 | Becton Dickinson and Company | Shares withheld for tax | −5,192 | — | — |
| Nov 20, 2024 | ResMed Inc. | Grant or award | +1,083 | — | — |
| Sep 7, 2024 | Becton Dickinson and Company | Shares withheld for tax | −466 | — | — |
| Sep 3, 2024 | ResMed Inc. | Grant or award | +267 | — | — |
| Sep 1, 2024 | Becton Dickinson and Company | Shares withheld for tax | −254 | — | — |
Questions about Christopher DelOrefice
What boards is Christopher DelOrefice on?
Christopher DelOrefice sits on the board of ResMed Inc.
How long has Christopher DelOrefice served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.